Latest Strategic Outlook News

Canterbury Resources has announced a non-underwritten Share Purchase Plan aiming to raise approximately $0.75 million at a 9.1% discount to recent trading prices, supporting exploration and working capital needs.

Artrya Limited has secured FDA 510(k) clearance for its Salix Coronary Plaque module, enabling near real-time detection of high-risk coronary artery plaque and opening a lucrative U.S. market opportunity with a $950 reimbursement per scan.

Janison Education Group reported a 9% revenue increase in FY25, driven by new contracts and the launch of its AI-powered assessment platform, Jai. The company also expanded its customer pipeline by 80%, positioning itself for sustained growth in digital education.

Janison Education Group reported a 9% revenue increase to $47 million in FY25, driven by new contracts and strong ICAS performance, while launching its AI-powered assessment platform Jai. The company also refreshed its leadership and expanded its customer pipeline to $28.6 million.

Super Retail Group reported record FY25 sales of AUD 4.07 billion, driven by store expansion and online growth, while statutory net profit declined 7.6% amid margin and cost pressures. The Board signals a strategic review to guide growth through 2030.

Euroz Hartleys Group Limited reported a robust 87.7% increase in net profit for FY25, driven by growth across brokerage, underwriting, and wealth management. The company declared a fully franked full-year dividend of 5.5 cents per share, reflecting confidence in its operational leverage and balance sheet strength.

Harmoney has delivered a robust FY25 performance, exceeding its upgraded profit guidance with strong loan book growth and improved efficiency. The fintech lender projects a remarkable 111% increase in cash NPAT for FY26, driven by its AI-powered Stellare 2.0 platform and strategic expansion plans.

MetalsTech Limited has completed critical in-adit channel sampling for its Sturec Gold Project, progressing its Pre-Feasibility Study (PFS) on track for late 2025 completion. The company is leveraging technological innovations to enhance recoveries and reduce environmental impact.

Pharmx Technologies reported a 13% increase in FY25 revenues to $7.53 million, driven by strong growth across its Gateway and Marketplace platforms. The company maintained positive EBITDA and a solid cash position despite legal expenses, setting the stage for an ambitious FY26 growth strategy.

Opthea Limited has terminated its sozinibercept wet AMD program following Phase 3 trial failures and settled a major funding agreement, setting the stage for a strategic reset.

Etherstack plc has delivered a record half year performance in H1 2025, driven by a landmark multi-year contract with AT&T and surging recurring revenues. The wireless communications specialist is poised for sustained growth across its core markets.

Energy One Limited reported a robust 17% revenue increase and a 309% jump in net profit for FY25, declaring its first dividend since FY23 and signaling ambitions to expand into the US market through acquisitions.